MEDIUMBuilt-inProduct / Revenue mix
OMNI
“10-K Item 1A: 'We believe that OMNI sales will continue to account for the majority of our revenue over the next twelve months.'”
SGHT · Concentration risk · 10-K extracted
Sight Sciences (SGHT) concentration risks
Updated
The most significant concentration Sight Sciences discloses is OMNI, classified MEDIUM by disclosed size. Below: the full set from the latest 10-K — verbatim quotes, filing references, and a synthesis of what these exposures mean together.
Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results.
Show full disclosure ▾Hide full disclosure ▴
About TrendMatrix. TrendMatrix is a publisher of general securities research and market commentary. We publish on a regular schedule. All content is the same for every subscriber in a tier — we do not provide personalized investment advice and we do not take into account any individual subscriber's financial situation, investment objectives, risk tolerance, tax situation, or holdings.
Not investment advice. TrendMatrix is not a registered investment adviser. Our content is for informational and educational purposes only. Consult your own licensed investment adviser, broker, or tax professional before making any investment decision.
Conflicts and positions. The TrendMatrix editorial team frequently holds personal long-term positions in securities discussed. We disclose positions held at the time of publication on each piece. We maintain a trading-window policy: we do not initiate or close positions in the same direction as a TrendMatrix publication within 24 hours before or 72 hours after publication.
No paid promotion. TrendMatrix does not accept payment from any issuer, broker, or third party in exchange for coverage of any security. Our sole compensation is subscription revenue.
No fiduciary duty. No fiduciary, advisory, or agency relationship is created between you and TrendMatrix by reading our content or subscribing to our service.
Performance. Past performance is not indicative of future results. Performance figures reflect the published model only and do not reflect any individual subscriber's actual results.
Source: Sight Sciences’s SEC Form 10-K filed — view the filing on SEC EDGAR ↗
At a glance
Disclosed-size breakdown · 1 disclosed concentration
HIGH0
MEDIUM1
LOW0
Disclosed concentrations
Each card carries a disclosed-size chip (HIGH / MEDIUM / LOW — how large the exposure is as a share of revenue, not how dangerous it is) and a nature tag: Built-in(the company’s own model, geography, or products) or Outside party (an external customer, supplier, or distributor it relies on).
TrendMatrix Research · concentration synthesis
What these concentrations mean together
updated 2026-08-23Sight Sciences' disclosed concentration risk is a single, medium-share, structural exposure to one product line. The company states that it believes OMNI sales will continue to account for the majority of its revenue over the next twelve months, meaning more than half of the business is expected to remain tied to this one surgical device rather than being spread across a diversified product portfolio. This is a structural feature of the company's current commercial stage rather than a dependency on a specific customer or supplier — the risk stems from demand for and adoption of OMNI itself. For an ophthalmic device company, a forward-looking majority-revenue dependence on a single product means that any slowdown in OMNI procedure volumes, competitive pressure, or a change in reimbursement conditions specific to that device would have a direct, largely unhedged effect on overall results, since the filing does not disclose a comparably sized secondary product line to offset it. No customer, supplier, or geographic concentration is disclosed in the reviewed filing excerpt, so the visible risk here is confined to this single-product revenue dependence rather than a broader operational or counterparty-based exposure.
For the engine’s reasoning on SGHT’s current verdict — including which dimensions drove the score — see the per-dimension breakdown.
Industry peers · Medical Devices
Peer concentration profile
| Symbol | Name | HIGH | MEDIUM | LOW | Total |
|---|---|---|---|---|---|
| AORT | Artivion, Inc. | 4 | 4 | 0 | 8 |
| ATEC | Alphatec Holdings, Inc. | 1 | 1 | 0 | 2 |
| ABT | Abbott Laboratories | 1 | 0 | 0 | 1 |
| SGHT● | Sight Sciences, Inc. | 0 | 1 | 0 | 1 |
| AHCO | AdaptHealth Corp. | 0 | 0 | 0 | 0 |
| AXGN | AxoGen, Inc. | 0 | 0 | 0 | 0 |
Concentration counts reflect items disclosed in each peer’s most recent 10-K; disclosed-size classification uses TrendMatrix’s internal 10-K extraction taxonomy.